Consider the following scenario: Ten-year survival rates for the four groups are 70%, 71%, 80%, and 82%, respectively, and the proportion of people developing troublesome side effects is 1%, 2%, 5%, and 50%.
Supóngase que las tasas de supervivencia a diez años para los cuatro grupos son 71%, 80%, 82% y 70%, respectivamente, y que la proporción de pacientes con efectos secundarios serios es 2%, 5%, 50% y 1%.